Syneron News

Syneron(TM) Technology to Be Featured in Six Presentations During the 2008 American Society for Laser Medicine and Surgery Conference

04/01/2008

Top Physicians and Academics to Highlight Results of elos-Based Treatments, Including ReFirme(TM), Matrix IR(TM) and VelaShape(TM) YOKNEAM, ISRAEL -- (MARKET WIRE) -- 03/31/2008 -- Syneron Medical Ltd.â�¢(NASDAQ: ELOS), an innovator in the development, marketing and sales of elosâ�¢ combined-energy medical aesthetic devices, today announced that six presenters, physicians and academics, will be speaking about Syneron`s non-invasive medical aesthetic devices during the annual conference of the American Society for Laser Medicine and Surgery (ASLMS) in Kissimmee, Fla., on April 2-6.

Syneron Invests in New Skin Whitening Technology

02/20/2008

YOKNEAM, ISRAEL -- (MARKET WIRE) -- 02/20/2008 -- Syneron Medical Ltd. (NASDAQ: ELOS) today announced that it has entered into an agreement with Rakuto Bio Technologies Ltd. (RBT), an Israeli-based start-up, to develop an advanced whole skin complexion whitening treatment.

/ CORRECTION - Syneron Medical Ltd.

02/12/2008

YOKNEAM, ISRAEL -- (MARKET WIRE) -- 02/12/2008 -- In the news release, "Syneron Reports Fourth Quarter 2008 Revenues of $38.1 Million, the Company`s Strongest Quarter Ever," issued earlier today by Syneron Medical Ltd. (NASDAQ: ELOS), we are advised by the company that the headline should read "Syneron Reports Fourth Quarter 2007 Revenues of $38.1 Million, the Company`s Strongest Quarter Ever" rather than "Syneron Reports Fourth Quarter 2008 Revenues of $38.1 Million, the Company`s Strongest Quarter Ever" as originally issued.

Syneron Reports Fourth Quarter 2007 Revenues of $38.1 Million, the Company`s Strongest Quarter Ever

02/11/2008

YOKNEAM, ISRAEL -- (MARKET WIRE) -- 02/11/2008 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosâ�¢ combined-energy medical aesthetic devices, today announced financial results for the fourth quarter and the full year ended December 31st, 2007.

Syneron(TM) Previews Matrix RF(TM) Ablative Fractional Device and Laser-Assisted Lipolysis System at American Academy of Dermatology Annual Meeting

01/31/2008

YOKNEAM, ISREAL -- (MARKET WIRE) -- 01/31/2008 -- Syneronâ�¢ Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosâ�¢ combined-energy medical aesthetic devices, today announced the company will preview two new technologies at the annual meeting of the American Academy of Dermatology (AAD) in San Antonio, Texas on February 2-4: the Matrix RFâ�¢ and a laser-assisted lipolysis system.